SCHEMBL6370898

SCHEMBL6370898

COc1cc(OC)c(N=C=O)cc1Br

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.56
ALDH1A1 P00352 2/20 0.56
HPGD P15428 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
PTPN1 P18031 2/20 0.37
TNFRSF1A P19438 1/20 0.37
HTR2A P28223 6/20 0.36
TAAR1 Q96RJ0 3/20 0.36
HTR2C P28335 2/20 0.36
HTR2B P41595 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PRKDC P78527 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8163649 0.86 CYP3A4 (0.66) CYP3A4ALDH1A1HPGDTDP1GRIN2D
SCHEMBL6372278 0.84 CYP3A4 (0.63) CYP3A4ALDH1A1HPGDTDP1GRIN2D
SCHEMBL542663 0.84 CYP3A4 (0.68) CYP3A4ALDH1A1HPGDTDP1GRIN2D
SCHEMBL6372027 0.79 CYP3A4 (0.58) CYP3A4ALDH1A1HPGDTDP1TAAR1
SCHEMBL1099873 0.79 CYP3A4 (0.53) CYP3A4ALDH1A1HPGDTDP1GRIN2D
SCHEMBL6377028 0.78 CYP3A4 (0.56) CYP3A4ALDH1A1HPGDTDP1KDM4E
SCHEMBL1457541 0.78 ALDH1A1 (0.56) CYP3A4ALDH1A1HPGDTDP1TAAR1
SCHEMBL668344 0.76 ALDH1A1 (0.54) CYP3A4ALDH1A1HPGDTDP1HTR2A
SCHEMBL1660244 0.76 ALDH1A1 (0.54) CYP3A4ALDH1A1HPGDTDP1KDM4E
SCHEMBL2301047 0.76 CYP3A4 (0.69) CYP3A4ALDH1A1HPGDTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2005-11-10 US disclosed
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-16 US disclosed
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-09 US disclosed
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PHARMACIA & UPJOHN COMPANY 2003-12-25 US disclosed
WO-2003093250-A2 POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR PHARMACIA & UPJOHN COMPANY (US) 2003-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885ALDH1A1 2007/4885HPGD 1692/4885
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885ALDH1A1 2007/4885HPGD 1692/4885
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 CYP3A4 1352/4885ALDH1A1 2007/4885HPGD 1692/4885
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA7, CHRNA1, CHRNA5 CYP3A4 1339/4885ALDH1A1 2742/4885HPGD 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.